Cryptococcus neoformans is an opportunistic pathogen that is responsible for life-threatening disease in patients with AIDS or other conditions of immunocompromise;extrapulmonary cryptococcal infection is an AIDS-defining illness. The long-term goal of our studies is to understand the pathogenesis of cryptococcosis. This application focuses on a fundamental part of this process, the interactions of this facultative intracellular pathogen with the phagocytic cells of its mammalian host. These interactions resolve with varying levels of damage to the host and yeast, but the mechanisms involved are poorly understood, limiting our ability to influence resolution in favor of the host. We propose to combine forward genetics, high-throughput screening assays, and focused follow-up studies to determine the cryptococcal factors that are required for this pathogen to successfully adhere to and enter host cells.
Aim I is to identify mutants in these processes, using insertional mutagenesis and automated screening.
Aim II is to determine the mechanisms by which selected gene products influence pathogen adherence and entry interactions. These studies will employ assays of cell adhesion, entry, and intracellular survival and growth;molecular techniques for sequence recovery, analysis, and gene deletion;and phenotypic assessment including morphological studies, biochemical analysis, and virulence assays. Results will be assessed using rigorous statistical methods and appropriate controls, and will be interpreted in the context of our expertise in the fundamental biology of Cryptococcus. The proposed studies will elucidate a crucial aspect of pathogenesis that determines the survival and dissemination of the organism and the host's ability to limit disease. This work will additionally open new areas for investigation of an important pathogen and develop experiment tools that can be applied to other areas of fungal biology.
This research is highly relevant to public health because the organism under study causes serious human illness for which current therapies are not adequate. The interactions of Cryptococcus neoformans with host cells are fundamental to its ability to cause disease, so understanding and inhibiting these processes may advance treatment of cryptococcal infection. Further, this work will contribute to basic science knowledge, which will provide insights into pathogenic microbes as well as other areas of biology.
|Srikanta, Deepa; Hole, Camaron R; Williams, Matthew et al. (2017) RNA Interference Screening Reveals Host CaMK4 as a Regulator of Cryptococcal Uptake and Pathogenesis. Infect Immun 85:|
|Santiago-Tirado, Felipe H; Onken, Michael D; Cooper, John A et al. (2017) Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen. MBio 8:|
|Santiago-Tirado, Felipe H; Doering, Tamara L (2016) All about that fat: Lipid modification of proteins in Cryptococcus neoformans. J Microbiol 54:212-22|
|Santiago-Tirado, Felipe H; Peng, Tao; Yang, Meng et al. (2015) A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic Outcome. PLoS Pathog 11:e1004908|
|Kumar, Pardeep; Heiss, Christian; Santiago-Tirado, Felipe H et al. (2014) Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly. Eukaryot Cell 13:560-71|
|Srikanta, Deepa; Santiago-Tirado, Felipe H; Doering, Tamara L (2014) Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast 31:47-60|
|Daniels, Brian P; Cruz-Orengo, Lillian; Pasieka, Tracy Jo et al. (2013) Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods 212:173-9|
|Srikanta, Deepa; Yang, Meng; Williams, Matthew et al. (2011) A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One 6:e22773|